Literature DB >> 30030707

Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes.

Mitsuo Terada1, Yayoi Adachi2, Masataka Sawaki2, Masaya Hattori2, Akiyo Yoshimura2, Gondo Naomi2, Haruru Kotani2, Madoka Iwase2, Ayumi Kataoka2, Sakura Onishi2, Kayoko Sugino2, Makiko Mori2, Nanae Horisawa2, Eiichi Sasaki3, Yasushi Yatabe3, Hiroji Iwata2.   

Abstract

PURPOSE: Occult breast cancer (OBC) is classified as a carcinoma of unknown primary, and involves axillary lymphadenopathy and is histologically consistent with metastatic breast cancer. OBC has been conventionally considered as a metastatic lymph node lesion, the origin of which is an undetectable breast tumor. Therefore, OBC patients would usually have undergone axillary lymph node dissection, and mastectomy or whole breast radiotherapy (WBRT). However, majority of OBC reports have been based on cases that were diagnosed during a period when diagnostics was still relatively primitive, and when magnetic resonance imaging was not yet a standard preoperative assessment. Therefore, there have been many false negatives in the breast based on preoperative assessment.
METHODS: We herein hypothesize that the origin of OBC is ectopic breast tissue present in axillary lymph nodes (ALNs). If our hypothesis is true, mastectomy and WBRT may be unnecessary for OBC patients.
RESULTS: Our hypothesis is supported by several findings. First, advances in radiological imaging have suggested that a primary breast tumor is absent in OBC patients. Second, proliferative breast lesions arising from ectopic breast present in ALNs have been reported. Lastly, cellular subtypes in OBC based on immunohistochemistry are of various types including ordinary breast cancer and the prognosis is not worse than stage II breast cancer.
CONCLUSION: It is important to distinguish between "primary" OBC in ALNs and "metastatic" OBC from micro-primary breast tumor. Further studies are required to determine if omission of mastectomy and WBRT is acceptable.

Entities:  

Keywords:  Breast inclusion; Ectopic breast; Occult breast cancer; Origin

Mesh:

Year:  2018        PMID: 30030707     DOI: 10.1007/s10549-018-4898-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

1.  Breast and Thyroid Surgery in 2021 and Beyond.

Authors:  Fausto Fama'
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

2.  Histologic Discordance Between Primary Tumor and Nodal Metastasis in Breast Cancer: Solving a Clinical Conundrum in the Era of Genomics.

Authors:  Nicole K Yun; Jessica A Slostad; Ankur Naqib; Casey Frankenberger; Claudia B Perez; Ritu Ghai; Lydia Usha
Journal:  Oncologist       Date:  2021-09-12

Review 3.  An occult urothelial carcinoma with wide multiorgan metastases and its genetic alteration profiling: Case report and literature review.

Authors:  Kunpeng Bu; Zeyan Shi; Yang Lu; Juan Zhao; Bixun Li
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

4.  The first case of gland inclusion in an intrapulmonary lymph node: a mimic of metastasis.

Authors:  Chenglong Wang; Yijia Cao; Min Zeng; Lijuan Wang; Xiaojing Cao; Lingfeng Zou; Youde Cao
Journal:  World J Surg Oncol       Date:  2019-11-04       Impact factor: 2.754

5.  Metastatic ductal adenocarcinoma of the breast presenting with pericardial effusion-Challenges in the diagnosis of breast cancer.

Authors:  Michael Chahin; Karan Seegobin; Satish Maharaj; Karishma Ramsubeik
Journal:  Clin Case Rep       Date:  2019-10-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.